USP Biologics is prioritizing the ongoing development of state-of-the-art analytical tools, standards and solutions to support regulatory predictability, allowing manufacturers to operate with a high level of confidence and certainty throughout the drug development and approval process across a variety of modalities.

Impurities pose risks to manufacturers, regulators and public health. USP can help.

USP is supporting the development of novel excipients.

Generic medicines are essential to improving patient access to important drug therapies.

Solving drug shortages: A call to action